Email this article Pregravidal preparation for women with hyperhomocysteinemia
- Authors: Ozolinya LA1, Kashezheva AZ2
-
Affiliations:
- ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва
- Городская поликлиника №68 Департамента здравоохранения г. Москвы
- Issue: Vol 15, No 2 (2013)
- Pages: 67-70
- Section: Articles
- URL: https://journals.rcsi.science/2079-5831/article/view/28222
- ID: 28222
Cite item
Abstract
The paper presents the results of a study of pregravidal training efficacy in women with hyperhomocysteinemia (HHC). 136 patients, among them: 30 women with mutations GGC against methylenetetrahydrofolate, 71 patients with GHz without this mutation and 35 women with normal levels of homocysteine (HC) in the blood plasma were constantly monitored. Risk factors for HHC were: anemia, hormonal contraception, diseases of the gastrointestinal tract, the lack of food folate, high coffee consumption (more than 2 cups per day), smoking. To reduce HC following treatment was appointed: folic acid (3 mg/day) and Vitrum Prenatal Forte multivitamin complex (1 tab/day). A significant decrease in the homocysteine concentration in blood plasma was noted on the first month of treatment, however, the level of GC in women who have not had methylenetetrahydrofolate mutation than in patients with this mutation was more reducing more quickly. Thanks to the adequate pregravidal preparation the majority of patients were able to normalize the level of homocysteine in blood and reduce the risk of obstetric complications in the event of pregnancy.
Full Text
##article.viewOnOriginalSite##About the authors
L A Ozolinya
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва
Email: ozolinya@yandex.ru
д-р мед. наук, проф. каф. акушерства и гинекологии №1 лечебного факультета
A Z Kashezheva
Городская поликлиника №68 Департамента здравоохранения г. Москвыканд. мед. наук, глав. врач ГП №68 г. Москвы
References
- Макаров О.В., Озолиня Л.А. Профилактика венозных тромбозов и тромбоэмболий в акушерстве и гинекологии. М., 2004.
- Макаров О.В., Керчелаева С.Б., Озолиня Л.А. Приобретенные и наследственные факторы тромбофилии в развитии осложнений беременности. М., 2006.
- Hayden M.R, Tyagi S.C. Homocysteine and reaсtive oxygen species in metabolic syndrome, type 2 diabetes mellitus and atheroscleropathy: The pleiotropic effects of folate supplementation. Nutr J 2004; 3 (4): 10–2.
- Nelen W.L, Blom H.J, Steegers E.A et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta - analysis. Fertil Steril 2000; 74: 1196–99.
- Rosenquist T.H, Ratashak S.A, Selhud J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 1995; 93: 1527–32.
- Wong W.Y, Eskes T.K.A.B, Kuijpers-Jagtman A.M et al. Nonsydromic orofascial clefts: association with maternal hyperhomocysteintmia. Teratology 1999; 60: 253–57.
- Доброхотова Ю.Э., Джобава Э.М., Хейдар Л.Х. и др. Значение фолиевой кислоты в акушерстве и перинатологии. Проблемы репродукции. 2006; 1: 98–101.
- Кошелева Н.Г. Современная тактика лечения и профилактики невынашивания беременности с учетом этиопатогенеза. Проблемы репродукции. 1997; 3: 45–50.
- Ахмедова Е.М. Гипергомоцистеинемия у беременных с гестозом. Автореф. дис … канд. мед. наук. М., 2003.
- Mignini L.E, Latthe P.M, Villar J et al. Mapping and theories of preeclampsia: the role of homocysteine. Obstet Gynecol 2005; 105: 411–25.
- Rajkovic A, Catalano P.M, Malinov M.R. Elevated homocysteine level with preeclampsia. Obstet Gynecol 1997; 90: 168–71.
- Eskes T.K. Clotting disorders and placental abruption: homocysteine – a new risk factor. Eur J Obstet Gynecol Reprod Biol 2001; 95: 206–12.
- Ozturk O, Saridogan E, Jauniaux E. Drug intervention in early pregnancy after assisted reproductive technology. Reprod Biomed Online 2004; 9 (4): 452–65.
- Кокрановское руководство. Беременность и роды. Пер. с англ. под ред. Г.Т.Сухих. М.: Логосфера, 2010.
Supplementary files
